The role played by the peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) activator, GW501516, in control of fatty acid metabolism: A new potential therapeutic target for treating metabolic syndrome

Endocrinology

Volumn 152, Issue 5, 2011, Pages 1742-1744

  Lee, Jandee ^a   Chung, Woong Youn ^b  

^a Ajou University School of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

[2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID; GW 0472; GW 1514; GW 610742; HYDROCORTISONE; LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA AGONIST; UNCLASSIFIED DRUG;

ABDOMINAL OBESITY; ARTICLE; BROWN ADIPOSE TISSUE; DYSLIPIDEMIA; FAT INTAKE; FATTY ACID METABOLISM; FATTY ACID OXIDATION; GLUCOSE INTOLERANCE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; METABOLIC SYNDROME X; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WHITE ADIPOSE TISSUE;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; FATTY ACIDS; HYPERTRIGLYCERIDEMIA; IMMUNOBLOTTING; LIVER; METABOLIC SYNDROME X; MICE; NUCLEAR PROTEINS; OXIDATION-REDUCTION; PHOSPHORYLATION; PPAR ALPHA; PPAR GAMMA; PPAR-BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; THIAZOLES; TRANS-ACTIVATORS; TRIGLYCERIDES;

EID: 79955420151     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2011-0211     Document Type: Article

References (22)

1. Eckel RH, Grundy SM, Zimmet PZ 2005 The metabolic syndrome. Lancet 365:1415-1428 (Pubitemid 40523737)
2. Flegal KM, Carroll MD, Ogden CL, Johnson CL 2002 Prevalence and trends in obesity among U. S. adults, 1999-2000. JAMA 288:1723-1727
3. Ford ES, Giles WH, Dietz WH 2002 Prevalence of the metabolic syndrome among U. S. adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287:356-359 (Pubitemid 34251969)
4. Grimaldi PA 2005 Regulatory role of peroxisome proliferator-activated receptor δ (PPARδ) in muscle metabolism. A new target for metabolic syndrome treatment? Biochimie (Paris) 87:5-8 (Pubitemid 40298758)
5. Lebovitz HE 2003 The relationship of obesity to the metabolic syndrome. Int J Clin Pract Suppl 134:18-27 (Pubitemid 36565032)
6. Björntorp P 1992 Abdominal obesity and the metabolic syndrome. Ann Med 24:465-468 (Pubitemid 23014471)
7. Türkoglu C, Duman BS, Günay D, Cagatay P, Ozcan R, Büyükdevrim AS 2003 Effect of abdominal obesity on insulin resistance and the components of the metabolic syndrome: evidence supporting obesity as the central feature. Obes Surg 13:699-705 (Pubitemid 37352552)
8. Adiels M, Olofsson SO, Taskinen MR, Borén J 2008 Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol 28:1225-1236
9. Chen W, Wang LL, Liu HY, Long L, Li S 2008 Peroxisome proliferator-activated receptor δ-agonist, GW501516, ameliorates insulin resistance, improves dyslipidaemia in monosodium L-glutamate metabolic syndrome mice. Basic Clin Pharmacol Toxicol 103:240-246
10. Barish GD, Narkar VA, Evans RM 2006 PPARδ: a dagger in the heart of the metabolic syndrome. J Clin Invest 116:590-597 (Pubitemid 43326863)
11. Takahashi S, Tanaka T, Sakai J 2007 New therapeutic target for metabolic syndrome: PPARδ. Endocr J 54:347-357 (Pubitemid 47105421)
12. Tenenbaum A, Motro M, Fisman EZ 2005 Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons. Cardiovasc Diabetol 16:14
13. Balakumar P, Rose M, Ganti SS, Krishan P, Singh M 2007 PPAR dual agonists: are they opening Pandora's box? Pharmacol Res 56:91-98 (Pubitemid 47304493)
14. Coll T, Alvarez-Guardia D, Barroso E, Gómez-Foix AM, Palomer X, Laguna JC, Vázquez-Carrera M 2010 Activation of peroxisome proliferator-activated receptor-δ by GW501516 prevents fatty acidinduced nuclear factor κB activation and insulin resistance in skeletal muscle cells. Endocrinology 151:1560-1569
15. Barroso E, Rodriguez-Calvo R, Serrano-Marco L, Astudillo AM, Balsinde J, Palomer X, Vazquez-Carrera M The PPARβ/δ activator GW501516 prevents the downregulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1α-lipin 1-PPARα pathway leading to increased fatty acid oxidation. Endocrinology 152:1848-1859
16. Oliver Jr WR, Shenk JL, Snaith MR, Russell CS, Plunket KD, Bodkin NL, Lewis MC, Winegar DA, Sznaidman ML, Lambert MH, Xu HE, Sternbach DD, Kliewer SA, Hansen BC, Willson TM 2001 A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport. Proc Natl Acad Sci USA 98:5306-5311 (Pubitemid 32397124)
17. Akiyama TE, Lambert G, Nicol CJ, Matsusue K, Peters JM, Brewer Jr HB, Gonzalez FJ 2004 Peroxisome proliferator-activated receptor β/δ regulates very low density lipoprotein production and catabolism in mice on a Western diet. J Biol Chem 279:20874-20881 (Pubitemid 38656484)
18. Krämer DK, Al-Khalili L, Guigas B, Leng Y, Garcia-Roves PM, Krook A 2007 Role of AMP kinase and PPAR δ in the regulation of lipid and glucose metabolism in human skeletal muscle. J Biol Chem 282:19313-19320 (Pubitemid 47100082)
19. Zheng Y, Zhang W, Pendleton E, Leng S, Wu J, Chen R, Sun XJ 2009 Improved insulin sensitivity by calorie restriction is associated with reduction of ERK and p70S6K activities in the liver of obese Zucker rats. J Endocrinol 203:337-347
20. Chakravarthy MV, Pan Z, Zhu Y, Tordjman K, Schneider JG, Coleman T, Turk J, Semenkovich CF 2005 "New" hepatic fat activates PPARα to maintain glucose, lipid, and cholesterol homeostasis. Cell Metab 1:309-322 (Pubitemid 43977168)
21. Chakravarthy MV, Lodhi IJ, Yin L, Malapaka RR, Xu HE, Turk J, Semenkovich CF 2009 Identification of a physiologically relevant endogeneous ligand for PPARα in liver. Cell 138:476-488
22. Lee CH, Olson P, Hevener A, Mehl I, Chong LW, Olefsky JM, Gonzalez FJ, Ham J, Kang H, Peters JM, Evans RM 2006 PPAR δ regulates glucose metabolism and insulin sensitivity. Proc Natl Acad Sci USA 103:3444-3449 (Pubitemid 43346488)